Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Video

» Live Case

TVT 2019: Live Case #15: NYP/Columbia — TAVR Sapien Ultra

June 25, 2019

Video

TVT 2019: Highlights From the Evolut Low-Risk Trial

June 13, 2019

Video

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

June 14, 2019

Video

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

June 14, 2019

Video

TVT 2019: Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

June 13, 2019

Video

» Interview

SURTAVI: TAVI vs SAVR Through 5 Years

November 6, 2021

Video

SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

June 26, 2018

Video

SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

June 26, 2018

Video

» Interview

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

November 4, 2021

Video

Optimal Hemodynamics- TAVI or SAVR- - L. Sondergaard

January 9, 2020

Video

» On Record

Hearing and Learning From Patients Undergoing AVR

November 25, 2024

Video

Failed Aortic Valve Bioprostheses- Valve-in-Valve or Redo-SAVR- - D. Dvir

January 9, 2020

Advertisement

TVT 2019: Live Case #15: NYP/Columbia — TAVR Sapien Ultra

TVT 2019: Highlights From the Evolut Low-Risk Trial

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

TVT 2019: Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

SURTAVI: TAVI vs SAVR Through 5 Years

SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Optimal Hemodynamics- TAVI or SAVR- - L. Sondergaard

Hearing and Learning From Patients Undergoing AVR

Failed Aortic Valve Bioprostheses- Valve-in-Valve or Redo-SAVR- - D. Dvir

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content